Submitted by Anonymous (not verified) on 5 July 2024 - 15:25
Opinion/decision on a Paediatric investigation plan (PIP): Regkirona, Regdanvimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0238/2023
Source: